ID

13592

Description

Study of XL999 in Patients With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00322673

Lien

https://clinicaltrials.gov/show/NCT00322673

Mots-clés

Versions (1)
  1. 18/02/2016 18/02/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

18 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Myeloid Leukemia NCT00322673

Anglais

Eligibility Acute Myeloid Leukemia NCT00322673

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)
Description

diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)

Type de données

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C1982687
UMLS CUI [3]
C0368761
ecog performance status of 0 or 1
Description

ecog performance status of 0 or 1

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
Description

subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1518321
UMLS CUI [2,1]
C0023467
UMLS CUI [2,2]
C0277556
adequate liver and renal function
Description

adequate liver and renal function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0232804
signed informed consent
Description

signed informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment
Description

anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0920425
hematopoietic stem cell transplantation within the previous 6 weeks
Description

hematopoietic stem cell transplantation within the previous 6 weeks

Type de données

boolean

Alias
UMLS CUI [1]
C1504389
immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999
Description

immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999

Type de données

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0018133
the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment
Description

the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C2004454
uncontrolled and/or concomitant illness
Description

uncontrolled and/or concomitant illness

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
pregnant or breastfeeding females
Description

pregnant or breastfeeding females

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known hiv
Description

known hiv

Type de données

boolean

Alias
UMLS CUI [1]
C0019682
Retour au début de la page

Similar models

Eligibility Acute Myeloid Leukemia NCT00322673

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)
boolean
C0023467 (UMLS CUI [1])
C1982687 (UMLS CUI [2])
C0368761 (UMLS CUI [3])
ecog
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
Item
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
boolean
C0023467 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
liver and renal function
Item
adequate liver and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
anticancer therapy
Item
anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment
boolean
C0920425 (UMLS CUI [1])
stem cell transplantation
Item
hematopoietic stem cell transplantation within the previous 6 weeks
boolean
C1504389 (UMLS CUI [1])
immunosuppressive therapy
Item
immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999
boolean
C0021079 (UMLS CUI [1])
C0018133 (UMLS CUI [2])
adverse events recovery
Item
the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment
boolean
C0877248 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
uncontrolled and/or concomitant illness
Item
uncontrolled and/or concomitant illness
boolean
C0009488 (UMLS CUI [1])
pregnant or breastfeeding females
Item
pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
hiv
Item
known hiv
boolean
C0019682 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial